MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0041820
Efedra Pharmaceuticals Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹8.21 Cr
▲ 32% YoY
Net profit · FY 2024
₹19.99 Lakh
Net margin 2.4%
EBITDA · FY 2024
₹31.61 Lakh
EBITDA margin 3.9%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹2.98 Lakh
Issued & subscribed
Open charges
₹1.72 Cr
Secured borrowings
Company age
9 yrs
Est. 2017
Employees · EPFO
26
Provident fund records
About Efedra Pharmaceuticals Private Limited
Data last updated:
Efedra Pharmaceuticals Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24239WB2017PTC223778. Its GSTIN is 19AAECE8690H1Z5 (West Bengal).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹2.98 Lakh. It is led by directors including Arindam Bhattacharya and Swati Roy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 28/52/3 Barisha Purba Para Road, Kolkata, West Bengal, India – 700063.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.21 Cr, a growth of 32% compared to the previous year. For the same year it recorded a net profit of ₹19.99 Lakh (net margin 2.4%) and EBITDA of ₹31.61 Lakh (EBITDA margin 3.9%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 23% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Efedra Pharmaceuticals. As per MCA filings, the company has open charges of ₹1.72 Cr on record. Court records list 1 case involving the company, including 1 filed against it.
Efedra Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0041820). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website efedra.in.
Company Details of Efedra Pharmaceuticals Private Limited
CIN U24239WB2017PTC223778
Registration Number 223778
Incorporation Date 08 December 2017
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-WB-10-0041820
Key People
Arindam Bhattacharya Director Swati Roy Additional Director Kaustav Mandal Additional Director Recognitions & Rankings of Efedra Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address28/52/3 Barisha Purba Para Road, Kolkata, West Bengal, India – 700063
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Efedra Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals operates one associated brand: Efedra Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceuticals in the critical care segment are provided, with a focus on formulating affordable medicines that address medical needs. | efedra.in |
Business Activity of Efedra Pharmaceuticals Private Limited
The main business activity of Efedra Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Efedra Pharmaceuticals Private Limited FY 2025 filings available
Efedra Pharmaceuticals Private Limited reported revenue of ₹8.21 Cr (up 32% YoY) for FY 2024.
Revenue · FY 2024
₹8.21 Cr ▲ 32%
Net profit · FY 2024
₹19.99 Lakh margin 2.4%
EBITDA · FY 2024
₹31.61 Lakh margin 3.9%
Compounded Annual Growth Rate (CAGR) of Efedra Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 11%
5 years · compounded
▲ 23%
EBITDA CAGR growth
1 year
▲ 32%
3 years · compounded
▲ 8%
5 years · compounded
▲ 81%
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 32% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Efedra Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹31.61 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19.99 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Efedra Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Efedra Pharmaceuticals are in the company report.
Premium access
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arindam Bhattacharya Also directs: Efexgene Pharmaceuticals Private Limited | Director | 08 Dec 2017 | 8 Years 10 Months | Current |
| Swati Roy Also directs: Roy Infosoft Private Limited | Additional Director | 11 Jul 2025 | 1 Years 3 Months | Current |
| Kaustav Mandal | Additional Director | 28 Oct 2025 | 0 Years 11 Months | Current |
Peer Comparison of Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Issar Pharmaceuticals Private Limited | ₹8.31 Cr (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Scitex Pharmaceuticals Private Limited | ₹8.31 Cr (FY 2024) | •••• | •••• | 2985.0% | •••• | Medchal, Telangana, India |
| Deepar Pharmaceuticals Private Limited | ₹8.3 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Jaipur, Rajasthan, India |
| Ravian Pharmaceuticals Limited | ₹8.28 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Patna, Bihar, India |
| Phyto Pharmaceuticals Pvt Ltd | ₹8.23 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Cuttack, Odisha, India |
| Efedra Pharmaceuticals Private Limited this company | ₹8.21 Cr (FY 2024) | •••• | •••• | 32.0% | •••• | Kolkata, West Bengal, India |
| Ags Pharmaceuticals Private Limited | ₹8.19 Cr (FY 2024) | •••• | •••• | -17.0% | •••• | Thirupathur, Tamil Nadu, India |
| Spansa Pharmaceuticals Private Limited | ₹8.15 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Patna, Bihar, India |
| KST Pharmaceuticals Private Limited | ₹8.12 Cr (FY 2024) | •••• | •••• | 552.0% | •••• | Hyderabad, Telangana, India |
| Convallaer Pharmaceuticals Private Limited | ₹8.1 Cr (FY 2024) | •••• | •••• | 36.0% | •••• | Kanpur, Uttar Pradesh, India |
| Rathnam Pharmaceuticals Private Limited | ₹8.03 Cr (FY 2018) | •••• | •••• | 52369.0% | •••• | Tirupati, Andhra Pradesh, India |
Peers are the five companies nearest above and the five nearest below Efedra Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals Private Limited is audited by PANKAJ AGARWALA & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| PANKAJ AGARWALA & ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Efedra Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Efedra Pharmaceuticals Private Limited
Open charges
₹1.72 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2025 | State Bank of India | ₹1.72 Cr | Open |
Total charge records: 1 View all charges
Legal Cases of Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 04 Oct 2026.
Total cases
1
Filed against the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Criminal case | Filed against the company by an individual | Disposed |
Premium access
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals Private Limited has a workforce of 26 employees as of Apr 02, 2024.
Employee count
26
Active EPFO establishments
1
Employee growth
4%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Kaustav Mandal was appointed as Additional Director on 28 Oct 2025.
Appointed
Kaustav Mandal was appointed as Additional Director.
AGM
Efedra Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 172.00 Lakh with Charge ID 101127615 was registered on 11 Jul 2025.
Appointed
Swati Roy was appointed as Additional Director.
Filing
Efedra Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Appointed
Arindam Bhattacharya was appointed as Director.
Appointed
Mohuya Chakroborty was appointed as Director.
Incorporation
08 Dec 2017
Efedra Pharmaceuticals Private Limited was registered on 08 Dec 2017 with Roc Kolkata I & aged 8 years 10 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Efedra Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Efedra Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Efedra Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAECE8690H1Z5 | West Bengal | Active | 02 Jan 2018 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Efedra Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Efedra Pharmaceuticals Private Limited
Efedra Pharmaceuticals is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 December 2017 (9+ years old) and is registered under CIN U24239WB2017PTC223778.
Efedra Pharmaceuticals reported revenue of ₹8.21 Cr for FY 2024 (up 32% YoY).
Efedra Pharmaceuticals has 3 current directors:
- Arindam Bhattacharya - Director
- Swati Roy - Additional Director
- Kaustav Mandal - Additional Director
Efedra Pharmaceuticals reported a net profit of ₹19.99 Lakh (net margin 2.4%) and EBITDA of ₹31.61 Lakh (EBITDA margin 3.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Efedra Pharmaceuticals is 11% over three years and 23% over five years. In the latest year (FY 2024) revenue rose 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Efedra Pharmaceuticals is 19AAECE8690H1Z5, registered in West Bengal.
The CIN (Corporate Identification Number) of Efedra Pharmaceuticals is U24239WB2017PTC223778. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Efedra Pharmaceuticals has 1 court case on record: 1 filed against it.
Efedra Pharmaceuticals was incorporated on 08 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Efedra Pharmaceuticals by revenue are Issar Pharmaceuticals Private Limited, Scitex Pharmaceuticals Private Limited, Deepar Pharmaceuticals Private Limited, Ravian Pharmaceuticals Limited, Phyto Pharmaceuticals Pvt Ltd and 5 more, all in the Pharma industry (Pharmaceuticals).
Kaustav Mandal was appointed as Additional Director on 28 Oct 2025. Swati Roy was appointed as Additional Director on 11 Jul 2025. Arindam Bhattacharya was appointed as Director on 08 Dec 2017. Efedra Pharmaceuticals has 4 board changes on record in total.